CalciMedica regains Nasdaq compliance after shares close above $1 for 10 straight sessions
CALC•Nasdaq minimum bid price compliance restored
CalciMedica regained compliance with Nasdaq’s $1 minimum bid price rule, removing a key listing risk.
Nasdaq staff confirmed the stock closed at $1 or more for 10 straight sessions from Aug. 31 to Sept. 14, 2026.
Prior deficiency deadline no longer outstanding
The company had faced a Sept. 14, 2026 deadline after falling below $1 for 30 consecutive business days.
No Nasdaq deficiency notices remained outstanding as of the Form 8-K filing date.
